These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34453788)

  • 21. Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis.
    Rimar D; Rosner I; Nov Y; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Daood R; Vadasz Z
    Arthritis Rheumatol; 2014 Mar; 66(3):726-30. PubMed ID: 24574233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between the serum level of vitamin D and systemic sclerosis in a Chinese population: a case control study.
    Zhang L; Duan Y; Zhang TP; Huang XL; Li BZ; Ye DQ; Wang J
    Int J Rheum Dis; 2017 Aug; 20(8):1002-1008. PubMed ID: 26619796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis.
    Yamaguchi Y; Ono J; Masuoka M; Ohta S; Izuhara K; Ikezawa Z; Aihara M; Takahashi K
    Br J Dermatol; 2013 Apr; 168(4):717-25. PubMed ID: 23110679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum concentrations of vascular endothelial growth factor in collagen diseases.
    Kikuchi K; Kubo M; Kadono T; Yazawa N; IHN H; Tamaki K
    Br J Dermatol; 1998 Dec; 139(6):1049-51. PubMed ID: 9990370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum B-cell activating factor assessment in a population of Egyptian patients with systemic sclerosis.
    Abdo MS; Mohammed RH; Raslan HM; Gaber SM
    Int J Rheum Dis; 2013 Apr; 16(2):148-56. PubMed ID: 23639027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [THE ROLE OF SEMAPHORIN 7A IN SYSTEMIC SCLEROSIS].
    Rimar D; Slobodin G; Rosner I; Rozenbaum M; Kaly L; Boulman N; Jiries N; Awisat A; Vadasz Z
    Harefuah; 2017 Jul; 156(7):418-421. PubMed ID: 28786275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Serum Vitamin D Levels in Patients with Systemic Sclerosis and Healthy Controls: Results of a Pilot Study.
    Gupta S; Mahajan VK; Yadav RS; Mehta KS; Bhushan S; Chauhan PS; Rawat R; Sharma V
    Indian Dermatol Online J; 2018; 9(4):250-255. PubMed ID: 30050814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement.
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
    Clin Rheumatol; 2005 Apr; 24(2):111-6. PubMed ID: 15349798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral blood mononuclear cells from patients with systemic sclerosis spontaneously secrete increased amounts of vascular endothelial growth factor (VEGF) already in the early stage of the disease.
    Bielecki M; Kowal K; Lapinska A; Chwiesko-Minarowska S; Chyczewski L; Kowal-Bielecka O
    Adv Med Sci; 2011; 56(2):255-63. PubMed ID: 21983449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement.
    De Santis M; Ceribelli A; Cavaciocchi F; Crotti C; Massarotti M; Belloli L; Marasini B; Isailovic N; Generali E; Selmi C
    Auto Immun Highlights; 2016 Dec; 7(1):5. PubMed ID: 26878864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].
    Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis.
    Michalska-Jakubus M; Kowal-Bielecka O; Smith V; Cutolo M; Krasowska D
    Microvasc Res; 2017 Mar; 110():24-31. PubMed ID: 27889559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased risk for bone loss in women with systemic sclerosis: a comparative study with rheumatoid arthritis.
    Kilic G; Kilic E; Akgul O; Ozgocmen S
    Int J Rheum Dis; 2016 Apr; 19(4):405-11. PubMed ID: 24283757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A vascular endothelial growth factor deficiency characterises scleroderma lung disease.
    De Santis M; Bosello SL; Capoluongo E; Inzitari R; Peluso G; Lulli P; Zizzo G; Bocci M; Tolusso B; Zuppi C; Castagnola M; Ferraccioli G
    Ann Rheum Dis; 2012 Sep; 71(9):1461-5. PubMed ID: 22402140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D levels in systemic sclerosis patients: a meta-analysis.
    An L; Sun MH; Chen F; Li JR
    Drug Des Devel Ther; 2017; 11():3119-3125. PubMed ID: 29138534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis.
    Yayla ME; İlgen U; Okatan İE; UsluYurteri E; Torgutalp M; Keleşoğlu Dinçer AB; Aydemir Gülöksüz EG; Sezer S; Turgay TM; Kınıklı G; Ateş A
    Clin Rheumatol; 2020 Jan; 39(1):77-83. PubMed ID: 31317426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Angiogenesis Factors in the Formation of Vascular Changes in Scleroderma by Assessment of the Concentrations of VEGF and sVEGFR2 in Blood Serum and Tear Fluid.
    Waszczykowska A; Goś R; Waszczykowska E; Dziankowska-Bartkowiak B; Podgórski M; Jurowski P
    Mediators Inflamm; 2020; 2020():7649480. PubMed ID: 32410862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis.
    Riccieri V; Stefanantoni K; Vasile M; Macrì V; Sciarra I; Iannace N; Alessandri C; Valesini G
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S46-52. PubMed ID: 21586218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1.
    Allanore Y; Borderie D; Lemaréchal H; Ekindjian OG; Kahan A
    Arthritis Res Ther; 2004; 6(4):R309-14. PubMed ID: 15225366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.